CEPMED Hosts Pioneers in Personalized Medicine in Montreal at the International Economic Forum

Share Article

CEPMED has attracted an impressive line-up of speakers to participate in a session devoted to personalized medicine at the International Economic Forum of the Americas on June 10 in Montreal. Speakers at the session, titled “Personalized Medicine: Stakes and Opportunities”, include Leroy Hood, Edward Abrahams, Raju Kucherlapati, Sharon Terry and Ryan Phelan.

Personalized Medicine: Stakes and Opportunities

CEPMED has attracted an impressive line-up of speakers to participate in a session devoted to personalized medicine at the International Economic Forum of the Americas on June 10 in Montreal. Speakers at the session, titled “Personalized Medicine: Stakes and Opportunities”, include Leroy Hood, Edward Abrahams, Raju Kucherlapati, Sharon Terry and Ryan Phelan.

The content of the session will focus on how personalized medicine can improve the efficacy, safety and cost-effectiveness of healthcare and how current expertise and technologies can be applied today to realize these benefits.

Leroy Hood is a world-leading scientist whose accomplishments includes inventing the automated DNA sequencer, founding the Institute for Systems Biology, and acting as an early advocate for and key player in the Human Genome Project. Edward Abrahams leads the most prominent organization for the promotion of PM; the Washington DC based Personalized Medicine Coalition. Raju Kucherlapati has spearheaded many successful initiatives in research and public education at the Harvard Medical School-Partners HealthCare Center for Genetics and was recently named by President Obama to participate in a blue ribbon White House panel on bioethics. Sharon Terry is a co-founder of the Genetic Alliance and an international advocate for genomic research on rare genetic diseases, an accomplishment motivated by the desire to help her own children who are afflicted by a genetic disease. Ryan Phelan is a serial social entrepreneur and consumer health advocate who started the first medical library for consumers, founded a nonprofit healthcare organization that led to a national model for humanizing US hospitals and founded Direct Medical Knowledge. She is founder and CEO of DNA Direct, a company that provides genetic expertise and Web-based decision support, and was recently acquired by Medco Health Solutions.

'Personalized Medicine: Stakes and Opportunities' is sponsored jointly by CEPMED, Genome Quebec and In Vivo Montreal. More information about the International Economic Forum and this session can be found at http://www.conferencedemontreal.com/en.

About CEPMED
Cepmed, the Center of Excellence in Personalized Medicine, is a non-profit organization dedicated to promoting the science and practice of personalized medicine through research, commercialization and education. It is a Centre of Excellence for Commercialization and Research (CECR) and supported by the Canadian Government, Genome Quebec as well as private partners including Pfizer, AstraZeneca, Novartis and Merck.

For additional information or for parties interested in attending the session (a limited number of free passes are available), please contact:

Katherine Bonter
Director of Advocacy and Promotion, Cepmed
Tel: (514) 670-7658
http://www.cepmed.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Katherine Bonter
Cepmed
(514) 670-7658
Email >
Visit website

Media